Naphthalene Exposure and Prostate Cancer Risk
There is no established causal link between naphthalene exposure and prostate cancer. The available evidence does not support naphthalene as a prostate carcinogen.
Evidence Assessment
What We Know About Naphthalene Carcinogenicity
Naphthalene is a polycyclic aromatic hydrocarbon (PAH) that has demonstrated carcinogenic effects in rodents, but these are limited to respiratory tissues only 1, 2:
- Rats: Olfactory epithelial nasal tumors (not in mice)
- Mice: Benign lung adenomas (not in rats)
- Humans: No identified association between naphthalene exposure and increased respiratory cancer risk 1
The mechanism involves initial metabolism to epoxide, followed by GSH depletion, cytotoxicity, chronic inflammation, and regenerative hyperplasia—supporting a non-mutagenic threshold mode of action 2. This mechanism operates specifically in respiratory tissues where naphthalene undergoes first-pass metabolism.
Why Prostate Cancer Is Not Implicated
Anatomical and metabolic considerations: Naphthalene's carcinogenic mechanism requires direct tissue contact and local metabolism in respiratory epithelium. The prostate is not a target organ for naphthalene toxicity because:
- It lacks the direct exposure pathway seen in nasal/lung tissues
- The metabolic activation occurs primarily at the site of inhalation exposure
- Systemic distribution after hepatic metabolism produces different metabolite profiles
Broader PAH Evidence
While the provided guidelines discuss PAH mixtures and cancer risk 3, they focus on lung, skin, and bladder cancers—not prostate cancer. Heavy occupational PAH exposure (coke-oven workers, aluminum production) shows established risks for these specific sites, but prostate cancer is notably absent from the documented cancer types.
The One Relevant Occupational Study
A nested case-control study of aerospace workers 4 examined occupational chemical exposures and prostate cancer, finding:
- Trichloroethylene (TCE) showed association with prostate cancer (OR 2.1 for high exposure, 95% CI 1.2-3.9)
- PAHs were evaluated but showed no significant association with prostate cancer
- This study specifically assessed PAH exposure alongside other chemicals and found no link
Clinical Bottom Line
Do not counsel patients that naphthalene exposure causes prostate cancer. If a patient has occupational or environmental naphthalene exposure and develops prostate cancer, this should be considered coincidental rather than causal. Focus prostate cancer risk counseling on established factors: age, family history, race/ethnicity, and genetic predisposition.
Important Caveat
The evidence for naphthalene and human cancer of any type remains limited 5. No epidemiologic studies of workers exposed solely to naphthalene exist, and no case reports of naphthalene-related cancers (including prostate) have been documented. The absence of evidence, combined with mechanistic understanding showing respiratory-specific effects, strongly argues against a prostate cancer link.